Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Satoshi Tsuboi is active.

Publication


Featured researches published by Satoshi Tsuboi.


Biochemical and Biophysical Research Communications | 1987

Significant effects of Z-Gln-Val-Val-OMe, common sequences of thiol proteinase inhibitors on thiol proteinases

Naoki Teno; Satoshi Tsuboi; Norio Itoh; Hiroshi Okamoto; Yoshio Okada

The first studies on a series of the small synthetic thiol proteinase inhibitors, conservative common sequences in several thiol proteinase inhibitors, are described. Among the many interesting findings with synthetic thiol proteinase inhibitors was the observation that the most effective analogue, Z-Gln-Val-Val-Ala-Gly-OMe, whose amino and carboxyl groups were protected with Z and OMe, respectively, showed inhibitory activity on papain and cathepsin B and protected papain from egg cystatin, human low-molecular-weight kininogen and T-kininogen-induced inhibition but not from leupeptin-induced inhibition. Moreover, it was revealed that Z-Gln-Val-Val-OMe was the smallest peptide to exhibit a protective effect on papain.


Biochemical and Biophysical Research Communications | 1989

Synthesis of peptide fragments related to eglin c and examination of their inhibitory effect on human leukocyte elastase, cathepsin G and α-chymotrypsin

Yoshio Okada; Satoshi Tsuboi; Yuko Tsuda; Kazunori Nakabayashi; Yoko Nagamatsu; Junichiro Yamamoto

Various kinds of peptide fragments related to eglin c were prepared by the conventional solution method and their inhibitory effects on human leukocyte elastase, cathepsin G and alpha-chymotrypsin were examined. Peptide (31-40) inhibited cathepsin G (Ki = 2.3 x 10(-4) M), peptide (41-49) potently inhibited cathepsin G and alpha-chymotrypsin (Ki = 4.2 x 10(-5) M and 2.0 x 10(-5) M, respectively), and peptide (60-63) inhibited leukocyte elastase (Ki = 1.6 x 10(-4) M), whereas, peptide (31-35) weakly inhibited both elastase and cathepsin G (Ki = 2.1 x 10(-3) M and 7.3 x 10(-4) M, respectively).


FEBS Letters | 1990

Synthesis of a trihexacontapeptide corresponding to the sequence 8–70 of eglin c and studies on the relationship between the structure and the inhibitory activity against human leukocyte elastase, cathepsin G and α-chymotrypsin

Yoshio Okada; Satoshi Tsuboi; Yuko Tsuda; Yoko Nagamatsu; Junichiro Yamamoto

A trihexacontapeptide corresponding to the sequence 8–70 of eglin c and its related peptides were synthesized by the conventional solution method and their inhibitory activity against human leukocyte elastase, cathepsin G and α‐chymotrypsin was examined. Although synthetic eglin c (41–49) inhibited cathepsin G and α‐chymotrypsin (K i = 4.0 × 10−5 M and 2.0 × 10−5 M, respectively) but not leukocyte elastase, the synthetic trihexaconta‐peptide potently inhibited cathepsin G, α‐chymotrypsin and leukocyte elastase (K i = 1.8 × 10−9 M, 1.4 × 10−9 M and 2.2 × 10−9 M, respectively). The relationship between the stucture of eglin c and the inhibitory activity against the above enzymes is also described.


Biochemistry | 1992

Crystal Structure of Papain-Succinyl-Gln-Val-Val-Ala-Ala-p-Nitroanilide Complex at 1.7-A Resolution: Noncovalent Binding Mode of a Common Sequence of Endogenous Thiol Protease Inhibitors?

Atsushi Yamamoto; Kouji Tomoo; Mitsunobu Doi; Hirofumi Ohishi; Masatoshi Inoue; Toshimasa Ishida; Daisuke Yamamoto; Satoshi Tsuboi; Hiroshi Okamoto; Yoshio Okada


Chemical & Pharmaceutical Bulletin | 1987

Amino acids and peptides. XVI: Synthesis of NG-tosylarginyl peptide derivatives-observation of lactam formation of arginyl residue

Luiz Juliano; Maria A. Juliano; Antonio Miranda; Satoshi Tsuboi; Yoshio Okada


International Journal of Peptide and Protein Research | 2009

Synthesis of human angiotensinogen (1-17) containing one of the putative glycosylation binding sites and its hydrolysis by human renin and porcine pepsin

Izaura Y. Hirata; Paulo Boschcov; Maria C. F. Oliveira; Maria A. Juliano; Antonio Miranda; Jair R. Chagas; Satoshi Tsuboi; Yoshio Okada; Luiz Juliano


International Journal of Peptide and Protein Research | 2009

Amino acids and peptides. XV: Synthesis of Gln-Val-Val-Ala-Gly and derivatives, a common sequence of thiol proteinase inhibitors and their effects on thiol proteinase

Naoki Teno; Satoshi Tsuboi; Yoshio Okada; Norio Itoh; Hiroshi Okamoto


Journal of The Chemical Society-perkin Transactions 1 | 1991

Amino acids and peptides. Part 32. Total synthesis of eglin c. Part 2. Synthesis of a heptacontapeptide corresponding to the entire amino acid sequence of eglin c and of related peptides, and studies on the relationship between the structure and inhibitory activity against human leukocyte elastase, cathepsin G and α-chymotrypsin

Yoshio Okada; Satoshi Tsuboi


Chemical & Pharmaceutical Bulletin | 1990

Amino acids and peptides. XXVIII, Synthesis of peptide fragments related to eglin c and studies on the relationship between their structure and effects on human leukocyte elastase, cathepsin G and α-chymotrypsin

Satoshi Tsuboi; Kazunori Nakabayashi; Yoshikazu Matsumoto; Naoki Teno; Yuko Tsuda; Yoshio Okada; Yoko Nagamatsu; Junichiro Yamamoto


Chemical & Pharmaceutical Bulletin | 1988

Amino acids and peptides. XX. Inhibition of papain by succinyl-Gln-Val-Val-Ala-Ala-p-nitroanilide, a common sequence of endogenous thiol proteinase inhibitors.

Yoshio Okada; Naoki Teno; Satoshi Tsuboi; Kazunori Nakabayashi; Norio Itoh; Hiroshi Okamoto; Norio Nishi

Collaboration


Dive into the Satoshi Tsuboi's collaboration.

Top Co-Authors

Avatar

Yoshio Okada

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Naoki Teno

Kobe Gakuin University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yuko Tsuda

Kobe Gakuin University

View shared research outputs
Top Co-Authors

Avatar

Norio Itoh

Kobe Gakuin University

View shared research outputs
Top Co-Authors

Avatar

Atsushi Yamamoto

Osaka University of Pharmaceutical Sciences

View shared research outputs
Top Co-Authors

Avatar

Toshimasa Ishida

Osaka University of Pharmaceutical Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge